PubRank

Michael Mauer

Author PubWeight™ 70.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 2010 3.87
2 Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 2003 2.16
3 Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007 2.08
4 An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int 2002 1.80
5 The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002 1.79
6 Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 2013 1.77
7 Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002 1.70
8 The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 2005 1.67
9 Histopathology of diabetic nephropathy. Semin Nephrol 2007 1.60
10 The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes 2005 1.40
11 Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients. Am J Nephrol 2015 1.39
12 Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 2005 1.34
13 Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int 2010 1.25
14 Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. Clin J Am Soc Nephrol 2010 1.24
15 Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrol Dial Transplant 2011 1.23
16 Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol 2003 1.21
17 Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis 2006 1.18
18 Diabetes and nephropathy. Curr Opin Nephrol Hypertens 2003 1.16
19 Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J Am Soc Nephrol 2006 1.16
20 Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol 2006 1.14
21 Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep 2013 1.09
22 GFR-estimating models in kidney transplant recipients on a steroid-free regimen. Nephrol Dial Transplant 2010 1.04
23 Comparison of methods for counting cells in the mouse glomerulus. Nephron Exp Nephrol 2006 1.03
24 Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 2013 1.01
25 Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol 2010 1.01
26 Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 2002 1.00
27 Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 2003 0.99
28 Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr Endocrinol Rev 2008 0.97
29 Fabry disease: dose matters. J Am Soc Nephrol 2014 0.97
30 The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Ophthalmology 2006 0.96
31 Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol 2008 0.96
32 Renal complications of Fabry disease in children. Pediatr Nephrol 2012 0.93
33 Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways. Diabetes 2006 0.92
34 Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care 2013 0.90
35 Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract 2008 0.89
36 Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes. Diabetes 2012 0.89
37 Assessment of renal pathology and dysfunction in children with Fabry disease. Clin J Am Soc Nephrol 2010 0.84
38 Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients. Diabetes 2008 0.83
39 Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications 2012 0.83
40 Estimating mean glomerular volume using two arbitrary parallel sections. J Am Soc Nephrol 2002 0.83
41 Temporal profile of diabetic nephropathy pathologic changes. Curr Diab Rep 2013 0.83
42 Reversal of diabetic nephropathy: lessons from pancreas transplantation. J Nephrol 2012 0.81
43 Morphologic features of declining renal function in type 1 diabetes. Semin Nephrol 2012 0.81
44 Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control. Diabetes Care 2011 0.81
45 Glomerular structure in the normal human kidney: differences between living and cadaver donors. J Am Soc Nephrol 2003 0.81
46 Effects of pancreas transplantation on the prevention and reversal of diabetic nephropathy. Contrib Nephrol 2011 0.80
47 Cellular basis of diabetic nephropathy: IV. Antioxidant enzyme mRNA expression levels in skin fibroblasts of type 1 diabetic sibling pairs. Nephrol Dial Transplant 2006 0.80
48 Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron 2002 0.80
49 Glomerular structural factors in progression of congenital nephrotic syndrome. Pediatr Nephrol 2003 0.80
50 Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation. Amino Acids 2013 0.79
51 Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. Clin J Am Soc Nephrol 2010 0.79
52 Cat-scratch disease relapse in a kidney transplant recipient. Pediatr Transplant 2007 0.79
53 Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitus. Arch Ophthalmol 2010 0.79
54 Comparing the automated versus manual method of needle biopsy for renal histology artefacts. Nephrol Dial Transplant 2008 0.78
55 Quantitating glomerular endothelial fenestration: an unbiased stereological approach. Am J Nephrol 2011 0.78
56 Enalapril accelerates remodeling of the renal interstitium after release of unilateral ureteral obstruction in rats. J Nephrol 2003 0.78
57 Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats. Am J Nephrol 2004 0.77
58 Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation. Nephrol Dial Transplant 2011 0.77
59 Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats. J Renin Angiotensin Aldosterone Syst 2007 0.76
60 Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes. J Diabetes Complications 2009 0.76
61 Predilection of segmental glomerulosclerosis lesions for the glomerulotubular junction area in type 1 diabetic patients: a novel mapping method. PLoS One 2013 0.75
62 Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study. Diabetes Metab Res Rev 2011 0.75
63 Olmesartan, microalbuminuria, and type 2 diabetes. N Engl J Med 2011 0.75
64 Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes. Diabetes Care 2013 0.75
65 Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2005 0.75
66 Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial. Diabetes Res Clin Pract 2013 0.75
67 Microalbuminuria in patients with cystic fibrosis. Diabetes Care 2011 0.75
68 Idiopathic intracranial hypertension immediately after kidney transplantation in a pediatric recipient. Pediatr Nephrol 2004 0.75
69 Erratum. Nephrol Dial Transplant 2017 0.75
70 A re-evaluation of the renal ablation model of progressive renal disease in rats. J Nephrol 2003 0.75
71 Lactic acidosis and hypoglycemia with ALL relapse following engrafted bone marrow transplant. Pediatr Blood Cancer 2009 0.75